As advised via PHARMAC Tender Results of 31 October 2019 there is to be a change in the listing and future sole supply of hydrocortisone cream 1% tube.

New listing from 1 April 2020

Hydrocortisone Cream 1% Pharmacy Health 100 gm OP                                             Pharmacode 2339765                    Schedule price $3.70

Incumbent brand

DermAssist Cream 1% 30 gm OP                                                                                          Pharmacode 2513137                    Schedule price $1.11

HSS (Hospital Supply Status) & CSS (Community Supply Status) commences 1 September 2020.

Brand switch fee for Community Pharmacy was not included in tender notification.

As of the date of this notification ProPharma / PWR cannot accept DermAssist Cream 1% 30 gm for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Benefit of staying with incumbent while stock remains available are minimal, but every cent counts: – the difference is purely the pack fee  where you potentially get 3 for dispensing DermAssist  Cream 1% 30 gm (3 packs equivalent) and 1 for Hydrocortisone Cream Pharmacy Health 100 gm.

You MUST manage your stock to avoid being caught with stock at the time sole supply commences 1 September 2020. Failure to do so may prove costly.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred by – supplier, wholesaler and pharmacy.

ProPharma / PWR will make a commercial decision in relation to stock holding which will potentially mean a change for pharmacy and patient. Unfortunately with the PHARMAC decision to have both new and incumbent products listed and fully funded until the commencement of the sole supply 1 September 2020 we need to act in the best interest of the company, pharmacy and patient. The patient will need to change, however wholesalers and pharmacy do not need to experience potential losses during the transition period.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author

Close